HighTower Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
45,922
+4,196
+10% +$1.77M 0.02% 689
2026
Q1
$19.7M Buy
41,726
+2,336
+6% +$1.18M 0.02% 619
2025
Q4
$18.4M Buy
39,390
+4,987
+14% +$2.32M 0.02% 638
2025
Q3
$14.7M Buy
34,403
+1,276
+4% +$495K 0.02% 705
2025
Q2
$12.7M Sell
33,127
-1,710
-5% -$616K 0.02% 714
2025
Q1
$12M Sell
34,837
-265
-0.8% -$85.2K 0.02% 696
2024
Q4
$10.5M Buy
35,102
+16,337
+87% +$5.71M 0.01% 732
2024
Q3
$7.61M Sell
18,765
-293
-2% -$107K 0.01% 860
2024
Q2
$6.13M Hold
19,058
0.01% 921
2024
Q1
$6.34M Sell
19,058
-1,169
-6% -$357K 0.01% 862
2023
Q4
$5.49M Sell
20,227
-11,454
-36% -$2.83M 0.01% 930
2023
Q3
$7.71M Buy
31,681
+7,322
+30% +$2M 0.01% 753
2023
Q2
$7.42M Buy
24,359
+10,619
+77% +$2.95M 0.01% 749
2023
Q1
$3.62M Sell
13,740
-7,697
-36% -$1.96M 0.01% 1000
2022
Q4
$5.13M Buy
21,437
+6,249
+41% +$1.4M 0.01% 842
2022
Q3
$2.79M Buy
15,188
+2,104
+16% +$419K 0.01% 1052
2022
Q2
$2.21M Buy
13,084
+559
+4% +$120K 0.01% 1206
2022
Q1
$3.17M Buy
12,525
+1,791
+17% +$450K 0.01% 1117
2021
Q4
$2.79M Buy
10,734
+2,613
+32% +$639K 0.01% 1182
2021
Q3
$1.97M Buy
8,121
+2,267
+39% +$554K 0.01% 1260
2021
Q2
$1.21M Buy
5,854
+830
+17% +$169K ﹤0.01% 1525
2021
Q1
$946K Sell
5,024
-7,444
-60% -$1.31M ﹤0.01% 1600
2020
Q4
$2.05M Sell
12,468
-3,762
-23% -$550K 0.01% 904
2020
Q3
$2.02M Sell
16,230
-2,225
-12% -$275K 0.01% 866
2020
Q2
$1.78M Sell
18,455
-12,123
-40% -$1.26M 0.01% 851
2020
Q1
$2.75M Sell
30,578
-12,827
-30% -$1.66M 0.02% 641
2019
Q4
$6.42M Buy
43,405
+4,114
+10% +$552K 0.04% 461
2019
Q3
$4.73M Sell
39,291
-594
-1% -$76.8K 0.03% 573
2019
Q2
$5.38M Sell
39,885
-377
-0.9% -$47.7K 0.03% 515
2019
Q1
$5.25M Buy
40,262
+7,097
+21% +$953K 0.04% 487
2018
Q4
$4.13M Buy
33,165
+12,050
+57% +$1.62M 0.03% 516
2018
Q3
$2.94M Sell
21,115
-1,646
-7% -$205K 0.02% 704
2018
Q2
$2.33M Buy
22,761
+376
+2% +$38K 0.02% 783
2018
Q1
$2.17M Buy
22,385
+8,666
+63% +$841K 0.02% 778
2017
Q4
$1.21M Sell
13,719
-399
-3% -$32.1K 0.01% 1017
2017
Q3
$1.12M Sell
14,118
-4,057
-22% -$326K 0.01% 1037
2017
Q2
$1.58M Sell
18,175
-14,852
-45% -$1.26M 0.01% 892
2017
Q1
$2.94M Buy
33,027
+23,711
+255% +$1.98M 0.03% 616
2016
Q4
$691K Sell
9,316
-3,446
-27% -$258K 0.01% 1122
2016
Q3
$972K Buy
12,762
+1,457
+13% +$112K 0.01% 929
2016
Q2
$871K Buy
11,305
+1,146
+11% +$90.5K 0.01% 942
2016
Q1
$791K Buy
10,159
+1,398
+16% +$97.6K ﹤0.01% 1151
2015
Q4
$594K Buy
8,761
+3,445
+65% +$240K 0.01% 1231
2015
Q3
$410K Buy
5,316
+977
+23% +$86.5K 0.01% 1297
2015
Q2
$394K Sell
4,339
-3,704
-46% -$297K 0.01% 1100
2015
Q1
$605K Buy
+8,043
New +$578K 0.01% 1009

Other funds holding HCA

HighTower Advisors's HCA Position: Q2 2026 in Review

HighTower Advisors increased its HCA Healthcare (HCA) stake by 10% in Q2 2026, buying an estimated $1.77M and bringing the position to 45,922 shares worth $17.9M. The position accounts for 0.02% of the portfolio, ranked #689.

HighTower Advisors first reported a position in HCA in Q1 2015 and has held it in 46 quarters since. The position peaked at $19.7M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • HighTower Advisors held 45,922 shares of HCA Healthcare worth $17.9M as of Q2 2026.
  • HighTower Advisors bought 4,196 HCA Healthcare shares in Q2 2026, an estimated $1.77M.
  • HCA Healthcare made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #689 holding.
  • HighTower Advisors first reported a position in HCA Healthcare in Q1 2015 and has held it in 46 quarters since.
  • HighTower Advisors's HCA Healthcare position peaked at $19.7M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.